1
|
Ho MW, Pick AS, Sutton DN, Dyker K, Cardale K, Gilbert K, Johnson J, Quantrill J, McCaul JA. Recruitment of patients into head and neck clinical trials: acceptability of studies to patients from perspective of the research team. Br J Oral Maxillofac Surg 2018. [PMID: 29523362 DOI: 10.1016/j.bjoms.2018.02.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
We reviewed longitudinal recruitment data to assess recruitment into head and neck cancer trials, and to identify factors that could influence this and affect their acceptability to patients. We retrieved data from the prospective computerised database (2009-2016) to measure acceptability to patients using the recruitment:screening ratio, and compared observational with interventional studies, single specialty (or site) with multispecialty (or site) studies, and "step-up" randomisation with "non-inferiority" randomisation designs. A total of 1283 patients were screened and 583 recruited. The recruitment:screening ratio for all National Institute for Health Research (NIHR) portfolio studies combined was 0.47 (486/1133). Studies that involved treatment by several specialties or at several sites had a significantly adverse impact on acceptability (p=0.01). Recruitment into non-inferiority randomised controlled studies was lower than that into step-up randomised studies (p=0.06). The complexity of a study's design did not compromise recruitment. Treatment across several specialties or several sites and perceived non-inferiority designs, reduced the acceptability of some trials.
Collapse
Affiliation(s)
- M W Ho
- Head and Neck Research, Bradford Institute of Health Research, Bradford Teaching Hospitals NHS Foundation Trust, West Yorkshire, UK; Oral and Maxillofacial Surgery, Leeds Dental Institute, University of Leeds, West Yorkshire LS2 9LU, UK.
| | - A S Pick
- Head and Neck Research, Bradford Institute of Health Research, Bradford Teaching Hospitals NHS Foundation Trust, West Yorkshire, UK
| | - D N Sutton
- Head and Neck Research, Bradford Institute of Health Research, Bradford Teaching Hospitals NHS Foundation Trust, West Yorkshire, UK
| | - K Dyker
- Head and Neck Research, Bradford Institute of Health Research, Bradford Teaching Hospitals NHS Foundation Trust, West Yorkshire, UK; Clinical Oncology, Leeds Teaching Hospitals NHS Trust, West Yorkshire, UK
| | - K Cardale
- Head and Neck Research, Bradford Institute of Health Research, Bradford Teaching Hospitals NHS Foundation Trust, West Yorkshire, UK; Clinical Oncology, Leeds Teaching Hospitals NHS Trust, West Yorkshire, UK
| | - K Gilbert
- Clinical Trials, Northwick Park Hospital, North-West London, UK
| | - J Johnson
- Head and Neck Research, Bradford Institute of Health Research, Bradford Teaching Hospitals NHS Foundation Trust, West Yorkshire, UK
| | - J Quantrill
- Head and Neck Research, Bradford Institute of Health Research, Bradford Teaching Hospitals NHS Foundation Trust, West Yorkshire, UK
| | - J A McCaul
- Clinical Trials, Northwick Park Hospital, North-West London, UK; Oral and Maxillofacial/Head and Neck Surgery, NHS Greater Glasgow and Clyde, Scotland
| |
Collapse
|